Frontiers
US$ 29.46
![glp 1 half life Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end Literature Review] AI-Driven Efficient De](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-025-08249-8/MediaObjects/42003_2025_8249_Figa_HTML.png)
glp 1 half life Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end Literature Review] AI-Driven Efficient De
Description
Diabetes Res Clin Pract 2022;183:109146.ArticlePubMed 80
![glp 1 half life Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end Literature Review] AI-Driven Efficient De](https://moonlight-paper-snapshot.s3.ap-northeast-2.amazonaws.com/arxiv/ai-driven-efficient-de-novo-design-of-glp-1ras-with-extended-half-life-and-enhanced-efficacy-4.png)
Affordability is the leading barrier to accessing care. Tracy Svenyach Affordability is the leading barrier to accessing care, Svenyach told The Nations Health
![glp 1 half life Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end Literature Review] AI-Driven Efficient De](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-16-00836/article_deploy/html/images/pharmaceuticals-16-00836-g001-550.jpg)
95% CI: 0.51 to 0.55
![glp 1 half life Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end Literature Review] AI-Driven Efficient De](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs00125-005-0128-9/MediaObjects/125_2005_128_Fig1_HTML.gif)
Not all GLP-1 formulations carry the same safety profile during breastfeeding
![glp 1 half life Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end Literature Review] AI-Driven Efficient De](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40262-018-0728-4/MediaObjects/40262_2018_728_Fig2_HTML.png)
Naturally derived compounds, with favorable safety profiles and the ability to powerfully suppress appetite and cravings, represent an appealing option for ongoing weight management
![glp 1 half life Enhanced plasma half-life and efficacy of engineered human albumin-fused -1 despite enzymatic cleavage of its C-terminal end Literature Review] AI-Driven Efficient De](https://framerusercontent.com/images/OwXZ7UmeOEB67vBOG5sqqUEYO4.png)